Increased risk of statin-associated autoimmune myopathy among American Indians

doi:10.1002/art.42126

. 2022 Sep;74(9):1602-1603.

doi: 10.1002/art.42126. Epub 2022 Jul 20.

Increased risk of statin-associated autoimmune myopathy among American Indians

Jennie Wei¹, Elizabeth Ketner¹, Andrew L Mammen²

Affiliations

PMID: 35333459
PMCID: PMC9531600
DOI: 10.1002/art.42126

Increased risk of statin-associated autoimmune myopathy among American Indians

Jennie Wei et al. Arthritis Rheumatol. 2022 Sep.

. 2022 Sep;74(9):1602-1603.

doi: 10.1002/art.42126. Epub 2022 Jul 20.

Authors

Jennie Wei¹, Elizabeth Ketner¹, Andrew L Mammen²

Affiliations

¹ Gallup Indian Medical Center, Gallup, NM.
² National Institutes of Health, Bethesda, MD.

PMID: 35333459
PMCID: PMC9531600
DOI: 10.1002/art.42126

No abstract available

PubMed Disclaimer

Cited by

Recent Updates on the Pathogenesis of Inflammatory Myopathies.
Musai J, Mammen AL, Pinal-Fernandez I. Musai J, et al. Curr Rheumatol Rep. 2024 Dec;26(12):421-430. doi: 10.1007/s11926-024-01164-7. Epub 2024 Sep 24. Curr Rheumatol Rep. 2024. PMID: 39316320 Free PMC article. Review.
Immune-Mediated Necrotizing Myopathies: Current Landscape.
Koumas C, Michelassi F. Koumas C, et al. Curr Neurol Neurosci Rep. 2024 May;24(5):141-150. doi: 10.1007/s11910-024-01337-y. Epub 2024 Apr 9. Curr Neurol Neurosci Rep. 2024. PMID: 38589696 Review.

References

1. Mammen AL. Statin-Associated Autoimmune Myopathy. The New England journal of medicine. 2016;374(7):664–669. - PubMed
1. Close RM, Close LM, Galdun P, Gerstberger S, Rydberg M, Christopher-Stine L. Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies. Rheumatology (Oxford). 2020. - PubMed
1. Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working G. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016. Neuromuscul Disord. 2018;28(1):87–99. - PubMed
1. Mammen AL, Gaudet D, Brisson D, et al. Increased frequency of DRB1*11:01 in anti-HMG-CoA reductase-associated autoimmune myopathy. Arthritis care & research. 2012. - PMC - PubMed
1. Tiniakou E, Rivera E, Mammen AL, Christopher-Stine L. Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors in statin-associated immune mediated necrotizing myopathy: a case-series. Arthritis Rheumatol. 2019. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Mammen AL. Statin-Associated Autoimmune Myopathy. The New England journal of medicine. 2016;374(7):664–669. - PubMed

[2] Mammen AL. Statin-Associated Autoimmune Myopathy. The New England journal of medicine. 2016;374(7):664–669. - PubMed

[3] Close RM, Close LM, Galdun P, Gerstberger S, Rydberg M, Christopher-Stine L. Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies. Rheumatology (Oxford). 2020. - PubMed

[4] Close RM, Close LM, Galdun P, Gerstberger S, Rydberg M, Christopher-Stine L. Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies. Rheumatology (Oxford). 2020. - PubMed

[5] Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working G. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016. Neuromuscul Disord. 2018;28(1):87–99. - PubMed

[6] Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working G. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016. Neuromuscul Disord. 2018;28(1):87–99. - PubMed

[7] Mammen AL, Gaudet D, Brisson D, et al. Increased frequency of DRB1*11:01 in anti-HMG-CoA reductase-associated autoimmune myopathy. Arthritis care & research. 2012. - PMC - PubMed

[8] Mammen AL, Gaudet D, Brisson D, et al. Increased frequency of DRB1*11:01 in anti-HMG-CoA reductase-associated autoimmune myopathy. Arthritis care & research. 2012. - PMC - PubMed

[9] Tiniakou E, Rivera E, Mammen AL, Christopher-Stine L. Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors in statin-associated immune mediated necrotizing myopathy: a case-series. Arthritis Rheumatol. 2019. - PubMed

[10] Tiniakou E, Rivera E, Mammen AL, Christopher-Stine L. Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors in statin-associated immune mediated necrotizing myopathy: a case-series. Arthritis Rheumatol. 2019. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Increased risk of statin-associated autoimmune myopathy among American Indians

Affiliations

Increased risk of statin-associated autoimmune myopathy among American Indians

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical